Ieq Capital LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,142 shares of the healthcare conglomerate's stock after selling 10,990 shares during the period. Ieq Capital LLC's holdings in UnitedHealth Group were worth $27,894,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of UNH. International Assets Investment Management LLC boosted its stake in shares of UnitedHealth Group by 78,814.4% during the third quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate's stock valued at $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. increased its position in UnitedHealth Group by 9,235.4% in the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate's stock valued at $458,929,000 after acquiring an additional 776,516 shares during the period. Caisse DE Depot ET Placement DU Quebec grew its stake in shares of UnitedHealth Group by 129.7% in the third quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate's stock worth $601,951,000 after purchasing an additional 581,324 shares during the last quarter. State Street Corp lifted its holdings in UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate's stock worth $26,626,387,000 after buying an additional 563,554 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG acquired a new stake in shares of UnitedHealth Group in the third quarter valued at about $276,785,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.
Insider Activity at UnitedHealth Group
In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction that occurred on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company's stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this hyperlink. 0.33% of the stock is owned by company insiders.
UnitedHealth Group Stock Down 7.3 %
Shares of NYSE UNH traded down $36.64 during trading on Friday, hitting $465.78. The stock had a trading volume of 16,946,496 shares, compared to its average volume of 4,697,853. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a market capitalization of $428.65 billion, a PE ratio of 30.09, a PEG ratio of 1.40 and a beta of 0.61. The firm has a fifty day moving average of $520.37 and a two-hundred day moving average of $561.26. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping the consensus estimate of $6.74 by $0.07. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $100.81 billion for the quarter, compared to analysts' expectations of $101.60 billion. During the same quarter last year, the firm earned $5.83 EPS. The company's quarterly revenue was up 6.8% compared to the same quarter last year. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.
Analyst Ratings Changes
A number of analysts have weighed in on UNH shares. Oppenheimer increased their target price on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an "outperform" rating in a research report on Friday, December 6th. Wells Fargo & Company lowered their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an "overweight" rating for the company in a research note on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft increased their price target on UnitedHealth Group from $595.00 to $625.00 and gave the stock a "buy" rating in a report on Tuesday, December 3rd. StockNews.com upgraded UnitedHealth Group from a "hold" rating to a "buy" rating in a research report on Thursday, January 23rd. Finally, Stephens raised their price target on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an "overweight" rating in a report on Thursday, December 5th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $629.32.
Read Our Latest Stock Report on UNH
About UnitedHealth Group
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Recommended Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.